Research Papers
Diagnostic performance and operational feasibility of the VISITECT CD4 lateral flow assay for advanced HIV disease in Kenyan public health facilities: A cross-sectional study.
The VISITECT CD4 rapid test demonstrated high sensitivity and reliability for identifying advanced HIV disease in Kenyan public health facilities. With 39.3% of participants having advanced HIV disease, exclusively among those who were virally unsuppressed, the findings support integrating VISITECT into targeted screening for high-risk patients, particularly in settings with limited access to conventional CD4 testing.
